Literature DB >> 1974674

Basic pharmacology of new long-acting sympathomimetics.

C G Löfdahl1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1974674     DOI： 10.1007/bf02718108

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  8 in total

1.  Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.

Authors:  A Ullman; N Svedmyr
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

2.  On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration.

Authors:  A B Jeppsson; C G Löfdahl; B Waldeck; E Widmark
Journal:  Pulm Pharmacol       Date:  1989

3.  Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig.

Authors:  H Ida
Journal:  Arzneimittelforschung       Date:  1976

4.  Effects of N-aralkyl substitution of beta-agonists on alpha- and beta-adrenoceptor subtypes: pharmacological studies and binding assays.

Authors:  N Decker; M C Quennedey; B Rouot; J Schwartz; J Velly
Journal:  J Pharm Pharmacol       Date:  1982-02       Impact factor: 3.765

5.  Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.

Authors:  C G Löfdahl; N Svedmyr
Journal:  Allergy       Date:  1989-05       Impact factor: 13.146

6.  Airway epithelium modulates the responsiveness of porcine bronchial smooth muscle.

Authors:  K Stuart-Smith; P M Vanhoutte
Journal:  J Appl Physiol (1985)       Date:  1988-08

7.  Respiratory epithelium inhibits bronchial smooth muscle tone.

Authors:  N A Flavahan; L L Aarhus; T J Rimele; P M Vanhoutte
Journal:  J Appl Physiol (1985)       Date:  1985-03

8.  Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.

Authors:  J Britton; S P Hanley; H V Garrett; J W Hadfield; A E Tattersfield
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139
  8 in total
  7 in total

Review 1.  Long- versus short-acting beta 2-agonists. Implications for drug therapy.

Authors:  L P Boulet
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 2.  Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  R N Brogden; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

Review 3.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

4.  The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.

Authors:  M Linden
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

5.  Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.

Authors:  P Anderson; J Lötvall; A Lindén
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 6.  Future developments in the pharmacotherapy of lung disease.

Authors:  A Van der Kuy
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

Review 7.  Combination therapy of long-acting beta agonists and inhaled corticosteroids in the management of chronic asthma.

Authors:  Harold S Nelson
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.